Skip to content
Agentic OS
Menu

Intelligence / Healthtech / De Novo Grants / Ventana Medical Systems, Inc.

Approvalsnovel device granted (FDA De Novo)5 Dec 2024

Ventana Medical Systems, Inc.

5 Dec 2024: Novel device granted (FDA De Novo) · VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001). Recorded in the openFDA device 510(k) (De Novo decisions).

View the source record

Granted
5 Dec 2024
Device
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001)
Specialty
Hematology
Product Code
SDP
Country
United States
Location
Tucson, AZ
Submitted
2024-05-29
Reference
DEN240025
What this signal means

A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.

  1. 2 added in the 30 days to 19 Nov 2026.
  2. Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS

Find the decision makers at Ventana Medical Systems, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Ventana Medical Systems, Inc. in our registers.

More in Hematology

De Novo Grants

See all

Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.